ERBB2 and triple-negative breast carcinoma: MCF-7 represents a ER and PR positive and HER2 negative breast cancer [31,99], whereas MDA-MB-231 represents a triple-negative breast cancer [31,100], which in the literature is associated to poor prognosis and fewer and less efficient treatments available [101].